FTC Asks Supreme Court To Hear Case On Antitrust Aspects Of Generic Drug Deals

In a case with wide implications for settlements of patent disputes in the drug industry, the U.S. Federal Trade Commission has asked the Supreme Court to hear its appeal of a...

Already a subscriber? Click here to view full article